Healthcare Keeps Evolving, Which Is More Worth Investors’ Attention, AbbVie or Pfizer? Oct 16, 2026 Life Science
These Two Companies Keep Raising Their Dividends at a Rapid Pace, and Long-Term Investors Could Reap Higher Returns Oct 14, 2026 Financial Service, Life Science
Moderna Stock Soars as New Cancer Research Initiative Ignites Market Enthusiasm Oct 10, 2026 Life Science
Bristol Myers Squibb’s Zenbexus Posts Win in Phase 3 Trial, What It Means for Investors Oct 9, 2026 Life Science
UBS Analyst Is Bullish on Eli Lilly, but Novo Nordisk Is Not Necessarily a Value Trap Oct 8, 2026 Life Science
Barclays Initiates Coverage of the U.S. Medical Technology Sector and Says Valuations Have Reached a Ten-Year Low Oct 7, 2026 Life Science
Option Care Health Receives $5.8 Billion Acquisition Offer, Stock Price Soars 33% in a Single Day Oct 7, 2026 Life Science
Pfizer’s High Dividend Is Undervalued by the Market, and Investors May Be Facing a Good Opportunity to Position Themselves Oct 6, 2026 Life Science
Johnson & Johnson Maintains Steady Dividends While Eli Lilly Bets on the Weight-Loss Drug Track Oct 2, 2026 Life Science
Lilly and Viking Just Showed the Obesity Market’s Next Phase — and It’s Not About Pounds Sep 30, 2026 Life Science
Competition Fears Are Overblown, and Eli Lilly’s Growth Engine Remains Strong Sep 30, 2026 Life Science
Summit Secures $2 Billion Investment From AstraZeneca, and the Two Parties Will Jointly Develop Anti-Cancer Drugs Sep 28, 2026 Life Science
